| # | Drug | Count |
|---|---|---|
| 0 | NATALIZUMAB | 772 |
| 1 | INTERFERON BETA-1A | 667 |
| 2 | DALFAMPRIDINE | 645 |
| 3 | ERGOCALCIFEROL | 412 |
| 4 | GABAPENTIN | 383 |
| 5 | DIMETHYL FUMARATE | 363 |
| 6 | BACLOFEN | 308 |
| 7 | OCRELIZUMAB | 281 |
| 8 | ASPIRIN | 258 |
| 9 | ASPIRIN 81 MG | 241 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERGOCALCIFEROL | 412 | 0.0139 |
| 1 | DALFAMPRIDINE | 645 | 0.0090 |
| 2 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 55 | 0.0045 |
| 3 | OCRELIZUMAB | 281 | 0.0045 |
| 4 | NATALIZUMAB | 772 | 0.0043 |
| 5 | BUPIVACAINE | 40 | 0.0043 |
| 6 | AMANTADINE | 53 | 0.0041 |
| 7 | TERIFLUNOMIDE | 172 | 0.0038 |
| 8 | SIPONIMOD | 32 | 0.0036 |
| 9 | BACLOFEN | 308 | 0.0036 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 775 |
| 1 | Interferon beta [EPC] | 687 |
| 2 | Potassium Channel Blocker [EPC] | 645 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 582 |
| 4 | Corticosteroid [EPC] | 518 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 459 |
| 6 | Provitamin D2 Compound [EPC] | 412 |
| 7 | Benzodiazepine [EPC] | 411 |
| 8 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 308 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 264 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 412 | 0.0138 |
| 1 | Potassium Channel Blocker [EPC] | 645 | 0.0090 |
| 2 | Integrin Receptor Antagonist [EPC] | 775 | 0.0089 |
| 3 | Adrenocorticotropic Hormone [EPC] | 7 | 0.0078 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 14 | 0.0067 |
| 5 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 6 | Pyrimidine Synthesis Inhibitor [EPC] | 172 | 0.0038 |
| 7 | Actinomycin [EPC] | 8 | 0.0036 |
| 8 | Interferon beta [EPC] | 687 | 0.0036 |
| 9 | Aldehyde Dehydrogenase Inhibitor [EPC] | 4 | 0.0035 |